Last edition
News about Market
Syngene International opens COVID-19 RT-PCR testing centre to support Bengaluru hospitals
Syngene International Ltd., a global research and development services company, today announced the opening of a COVID-19 testing laboratory at its Bengaluru site. In less than six weeks, the company used its expertise in clinical trial management
Market | 28/04/2020 | By Darshana | 733
Today, the U.S. Food and Drug Administration granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy) for the treatment of adult patients with triple-negative breast cancer that has spread to other parts of the body. Patients must have received at least two prior therapies before taking Trodelvy
Market | 25/04/2020 | By Darshana | 626
Uber partners Medlife to ensure medicine deliveries across 5 cities
As our battle as a people against COVID-19 intensifies, and stricter norms get put in place to flatten the curve, it is crucial that we all stay at home, and that we stay healthy while at home
Market | 19/04/2020 | By Darshana | 277
Lupin's Mandideep Unit II Facility Receives EIR from U.S. FDA
Pharma major Lupin Limited (Lupin) today announced the receipt of the Establishment Inspection Report (EIR) after closure of the U.S. FDA inspection of its Mandideep Unit II facility, classifying the inspection as Voluntary Action Indicated. The inspection at the facility was carried out by the U.S. FDA between November 26, 2018 and December 4, 2018
Market | 15/04/2020 | By Darshana | 268
BELLUS Health Inc, a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that it has entered into an asset purchase and sale agreement to acquire all of the remaining BLU-5937 and related P2X3 antagonists intellectual property assets.
Market | 24/03/2020 | By Darshana | 603
Sun Pharma Launches RIOMET ER Oral Suspension in the U.S.
Sun Pharmaceutical Industries Ltd. today announced that one of its wholly-owned subsidiaries has launched Riomet ER in the U.S. as an adjunct to diet and exercise to improve glycemic control in patients 10 years of age and older with type 2 diabetes mellitus. Riomet ER was approved by the U.S. Food and Drug Administration (FDA) on August 29, 2019
Market | 14/03/2020 | By Darshana | 302
India curbs key drug exports as worldwide coronavirus scare grows
India, the world's main supplier of generic drugs, has restricted the export of 26 pharmaceutical ingredients and the medicines made from them, including Paracetamol, a common pain reliever also sold as acetaminophen, as the coronavirus outbreak plays havoc with supply chains
Market | 12/03/2020 | By Darshana | 826
Coronavirus: World pharma supplier India restricts export of some ingredients, drugs
The coronavirus outbreak has disrupted businesses dependent on Chinese supplies and industry professionals say Indian generic drugmakers are likely to face supply shortages from China if the epidemic drags on. Indian pharma companies get almost 70% of the active pharmaceutical ingredients for their medicines from China.
Market | 11/03/2020 | By Darshana | 522
Pharma Industry Likely To Reach $100 Billion: Gowda
D V Sadananda Gowda, Minister of Chemicals and Fertilizers, Govt of India today said that the Indian pharmaceuticals and medical devices sector has the potential to become the world leader and government will provide all necessary support.
Market | 06/03/2020 | By Darshana | 440
Coronavirus impact: Is there hope for Indian pharma beyond Ides of March?
Time is ticking and Indian pharmaceutical units dependent on crucial raw materials from China - active pharmaceutical ingredients and key starting materials to make medicines in India - are waiting and watching developments unfold this month.
Market | 03/03/2020 | By Darshana | 218
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy